Skip to content

Effect of esketamine on preventing chronic postsurgical pain in breast cancer patients with preoperative depression: A randomized controlled trial

Effect of esketamine on preventing chronic postsurgical pain in breast cancer patients with preoperative depression: A randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079355
Enrollment
Unknown
Registered
2024-01-01
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic postsurgical pain

Interventions

experimental group:esketamine
control group:Normal saline

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective unilateral mastectomy with or without axillary surgery under general anesthesia. 2. Age 18-65 years. 3. BMI 18-30 kg/m2. 4. ASA grade I-III. 5. Preoperative depression score = 8 points (HADS-D 0-21 scale).

Exclusion criteria

Exclusion criteria: bilateral breast surgery, previous history of same-side breast surgery within the past three years; preoperative history of chronic pain; hypertension and diabetes; preoperative language communication and cognitive impairment; history of severe mental or neurological disorders, drug abuse or psychiatric medication misuse, severe visual and hearing impairments, and contraindications related to esketamine.

Design outcomes

Primary

MeasureTime frame
Incidence of chronic postsurgical pain at 3 and 6 months;Postoperative adverse effects;

Secondary

MeasureTime frame
Sufentanil consumption for first 48h postoperatively;NRS scores at different time after surgery;Postoperative sleep quality;Postoperative anxiety and depression scores;Incidence of postoperative neuropathic pain at 3 months and 6 months ;

Countries

China

Contacts

Public ContactYang Jianjun

The First Affiliated Hospital of Zhengzhou University

jianjunyang1971@163.com+86 137 8353 7619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026